Your browser doesn't support javascript.
loading
Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies.
D'Onofrio, Alice; Gano, Lurdes; Melo, Rita; Mendes, Filipa; Oliveira, Maria Cristina; Denoël, Thibaut; Schaefer, Niklaus; Viertl, David; Fierle, Julie; Coukos, George; Dunn, Steven; Prior, John O; Paulo, António.
Affiliation
  • D'Onofrio A; C(2)TN- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal.
  • Gano L; C(2)TN- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal; DECN - Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal.
  • Melo R; C(2)TN- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal.
  • Mendes F; C(2)TN- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal; DECN - Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal.
  • Oliveira MC; C(2)TN- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal; DECN - Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal.
  • Denoël T; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Schaefer N; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Viertl D; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Fierle J; LAbCore, Ludwig Institute for Cancer Research, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Coukos G; Ludwig Institute for Cancer Research and Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Dunn S; LAbCore, Ludwig Institute for Cancer Research, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Prior JO; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Paulo A; C(2)TN- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal; DECN - Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal. Electronic address: apaulo@ctn.tecnico.ulisboa.pt.
Eur J Pharm Biopharm ; 158: 233-244, 2021 Jan.
Article de En | MEDLINE | ID: mdl-33271301
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antigènes CD / Radioimmunothérapie / Immunoconjugués / Anticorps à chaîne unique / Antigènes néoplasiques / Tumeurs Type d'étude: Prognostic_studies Limites: Animals / Female / Humans Langue: En Journal: Eur J Pharm Biopharm Sujet du journal: FARMACIA / FARMACOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Portugal Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antigènes CD / Radioimmunothérapie / Immunoconjugués / Anticorps à chaîne unique / Antigènes néoplasiques / Tumeurs Type d'étude: Prognostic_studies Limites: Animals / Female / Humans Langue: En Journal: Eur J Pharm Biopharm Sujet du journal: FARMACIA / FARMACOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Portugal Pays de publication: Pays-Bas